| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Regulatory Officer | EVP, Global Head Ra &Quality
1 company
Henrich Jill is an EVP, Chief Regulatory Officer at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $156K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | ATRA Atara Biotherapeutics, Inc. | EVP, Chief Regulatory Officer | Sell | 1,059 | $7.00 | $7,409.82 | -5.4% | +14.3% | -22.6% | |
| Nov 18, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Chief Regulatory Officer | Sell | 1,000 | $11.20 | $11,198.00 | -4.9% | -28.7% | +18.8% | |
| Aug 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 963 | $6.63 | $6,383.99 | -2.3% | +82.2% | +75.3% | |
| May 16, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 25,750 | $0.62 | $15,887.75 | -4.6% | -48.8% | -54.7% | |
| Mar 4, 2024 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,879 | $0.72 | $2,792.88 | -0.7% | -23.0% | -62.0% | |
| Nov 16, 2023 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,267 | $0.39 | $1,270.86 | -3.0% | +60.3% | -0.1% | |
| Aug 16, 2023 | ATRA Atara Biotherapeutics, Inc. | EVP, Global Head Ra &Quality | Sell | 3,346 | $1.65 | $5,531.50 | -1.5% | -79.4% | -83.8% |